Vaccine Development PlatformsViral vectored Vaccine Technologies have emerged as a promising platform, leveraging the intrinsic adjuvant properties of viruses to deliver recombinant antigens. Adenovirus and poxvirus vectors have demonstrated strong immunogenicity in clinical trials for various pathogens including influenza, Ebola, HIV etc.Self-amplifying RNA and DNA vaccines are novel platforms...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian